Pharma Two B
Striving to improve patients’ quality of life by developing innovative combination products, based on previously approved drugs, with favorable balance between safety and efficacy.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
$30.0m | Series C | ||
| Total Funding | 000k | ||
Related Content
Pharma Two B focuses on developing innovative pharmaceutical products by leveraging previously approved drugs. The company aims to enhance the potential of these drugs by optimizing their mechanism of action, adjusting doses, and improving delivery methods. Additionally, Pharma Two B explores synergistic effects in combination products to create more effective treatments. The primary clients include healthcare providers and pharmaceutical companies looking for advanced therapeutic solutions. Operating in the pharmaceutical and biotechnology market, Pharma Two B employs a business model centered on research and development, followed by licensing and partnerships to bring their products to market. Revenue is generated through licensing agreements, milestone payments, and royalties from product sales.
Keywords: drug development, optimized doses, delivery modes, synergistic effects, combination products, healthcare providers, pharmaceutical companies, research and development, licensing, royalties.
Tech stack
Investments by Pharma Two B
Edit